OncoMatch

OncoMatch/Clinical Trials/NCT07642362

Digital Support for Multiple Myeloma Quality of Life

Is NCT07642362 recruiting? Yes, currently enrolling (Jul 2026). This NA trial studies non-drug interventions for multiple myeloma.

NARecruitingCareAcrossNCT07642362Data as of Jul 2026Location: Greece

The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform. Specifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.

Check if I qualify

Extracted eligibility criteria

Cancer type

Multiple Myeloma

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07642362 currently recruiting?

Yes, this trial is currently recruiting patients.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify